Compounds having the Formula (I), including pharmaceutically acceptable salts thereof, ##STR00001## wherein at least one of X.sup.1, X.sup.2 or X.sup.3 is ##STR00002## and any remaining X.sup.1, X.sup.2 or X.sup.3 is hydrogen, which are useful as kinase inhibitors, wherein R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5, R.sup.6, A.sup.1, A.sup.2 and m are as described herein.